TickerKhojICICI Prudential Mutual Fund · Index Funds · Equity Index · Direct plan
ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth
₹20.9974NAV on 30 Oct 2026Expense ratio 0.51%
29 Oct 2025NAV low 16.65 · high 21.06+21.1%
In plain words
Over 3 years it returned +22.5% a year, against +7.4% for its benchmark index.
Its worst fall from a peak in the last 3 years was -16.6%.
On 3-year return it ranks 3 of 149 funds in Equity Index.
A monthly SIP over 3 years ended ₹5,016 higher in the direct plan than the regular plan, because of the lower expense ratio.
Past returns, not a promise of future returns or a recommendation.
Returns vs benchmark
| Period | Fund | Benchmark |
|---|---|---|
| 1 month | +2.6% | +1.9% |
| 3 months | +2.9% | -5.1% |
| 6 months | +16.7% | -3.2% |
| 1 year | +21.8% | -10.2% |
| 3 years (yearly) | +22.5% | +7.4% |
| Since start (yearly) | +21.3% | +11.2% |
Monthly SIP of ₹10,000
| Period | Invested | Value now | Yearly return |
|---|---|---|---|
| 1 year | ₹1,20,000 | ₹1,38,777 | +26.4% |
| 3 years | ₹3,60,000 | ₹4,68,969 | +17.1% |
Other plan of this fund: ICICI Prudential Nifty Pharma Index Fund - Regular Plan - Growth